{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:36:52Z","timestamp":1792460212520,"version":"4.5.0"},"reference-count":253,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p>Huntington\u2019s disease (HD) is an autosomal dominant genetic disorder caused by an expansion of the CAG repeat in the first exon of Huntingtin\u2019s gene. The associated neurodegeneration mainly affects the striatum and the cortex at early stages and progressively spreads to other brain structures. Targeting HD at its earlier stages is under intense investigation. Numerous drugs were tested, with a rate of success of only 3.5% approved molecules used as symptomatic treatment. The restoration of cholesterol metabolism, which is central to the brain homeostasis and strongly altered in HD, could be an interesting disease-modifying strategy. Cholesterol is an essential membrane component in the central nervous system (CNS); alterations of its homeostasis have deleterious consequences on neuronal functions. The levels of several sterols, upstream of cholesterol, are markedly decreased within the striatum of HD mouse model. Transcription of cholesterol biosynthetic genes is reduced in HD cell and mouse models as well as post-mortem striatal and cortical tissues from HD patients. Since the dynamic of brain cholesterol metabolism is complex, it is essential to establish the best method to target it in HD. Cholesterol, which does not cross the blood-brain-barrier, is locally synthesized and renewed within the brain. All cell types in the CNS synthesize cholesterol during development but as they progress through adulthood, neurons down-regulate their cholesterol synthesis and turn to astrocytes for their full supply. Cellular levels of cholesterol reflect the dynamic balance between synthesis, uptake and export, all integrated into the context of the cross talk between neurons and glial cells. In this review, we describe the latest advances regarding the role of cholesterol deregulation in neuronal functions and how this could be a determinant factor in neuronal degeneration and HD progression. The pathways and major mechanisms by which cholesterol and sterols are regulated in the CNS will be described. From this overview, we discuss the main clinical strategies for manipulating cholesterol metabolism in the CNS, and how to reinstate a proper balance in HD.<\/jats:p>","DOI":"10.3389\/fnagi.2022.797220","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T14:04:10Z","timestamp":1650377050000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":74,"title":["Altered Cholesterol Homeostasis in Huntington\u2019s Disease"],"prefix":"10.3389","volume":"14","author":[{"given":"Radhia","family":"Kacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coline","family":"Mounier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyne","family":"Caboche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Betuing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"12799","DOI":"10.1074\/jbc.M601019200","article-title":"24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux.","volume":"281","author":"Abildayeva","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1007\/s12035-015-9303-2","article-title":"Role of Rho Kinase Inhibition in the Protective Effect of Fasudil and Simvastatin Against 3-Nitropropionic Acid-Induced Striatal Neurodegeneration and Mitochondrial Dysfunction in Rats.","volume":"53","author":"Ahmed","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0014-5793(90)81107-y","article-title":"Rates of cholesterol, ubiquinone, dolichol and dolichyl-P biosynthesis in rat brain slices.","volume":"269","author":"Andersson","year":"1990","journal-title":"FEBS Lett."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1073\/pnas.0500634102","article-title":"Inactivation of liver X receptor beta leads to adult-onset motor neuron degeneration in male mice.","volume":"102","author":"Andersson","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"B5","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death.","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/00005072-199704000-00013","article-title":"Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington\u2019s disease\u2013an in situ hybridization study.","volume":"56","author":"Arzberger","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/jnnp.2010.208264","article-title":"Longitudinal change in regional brain volumes in prodromal Huntington disease.","volume":"82","author":"Aylward","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152564","article-title":"Statin Use and the Risk of Parkinson\u2019s Disease: An Updated Meta-Analysis.","volume":"11","author":"Bai","year":"2016","journal-title":"PloS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1126\/science.aax3338","article-title":"Huntington\u2019s disease alters human neurodevelopment.","volume":"369","author":"Barnat","year":"2020","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease.","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1093\/brain\/awf180","article-title":"Impaired glutamate transport and glutamate\u2013glutamine cycling: downstream effects of the Huntington mutation.","volume":"125","author":"Behrens","year":"2002","journal-title":"Brain"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00278","article-title":"Elusive roles for reactive astrocytes in neurodegenerative diseases.","volume":"9","author":"Ben Haim","year":"","journal-title":"Front. Cell. Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1523\/JNEUROSCI.3516-14.2015","article-title":"The JAK\/STAT3 Pathway Is a Common Inducer of Astrocyte Reactivity in Alzheimer\u2019s and Huntington\u2019s Diseases.","volume":"35","author":"Ben Haim","year":"","journal-title":"J. Neurosci."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109308","article-title":"Cell-intrinsic glial pathology is conserved across human and murine models of Huntington\u2019s disease.","volume":"36","author":"Benraiss","year":"2021","journal-title":"Cell Rep."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11758","article-title":"Human glia can both induce and rescue aspects of disease phenotype in Huntington disease.","volume":"7","author":"Benraiss","year":"2016","journal-title":"Nat. Commun."},{"key":"B16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cell.2008.04.052","article-title":"LXR signaling couples sterol metabolism to proliferation in the acquired immune response.","volume":"134","author":"Bensinger","year":"2008","journal-title":"Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41593-020-00757-6","article-title":"Microglia facilitate repair of demyelinated lesions via post-squalene sterol synthesis.","volume":"24","author":"Berghoff","year":"2021","journal-title":"Nat. Neurosci."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012519","article-title":"Striatal infusion of cholesterol promotes dose-dependent behavioral benefits and exerts disease-modifying effects in Huntington\u2019s disease mice.","volume":"12","author":"Birolini","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jconrel.2020.12.051","article-title":"Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington\u2019s disease.","volume":"330","author":"Birolini","year":"","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1093\/brain\/awab186","article-title":"SREBP2 gene therapy targeting striatal astrocytes ameliorates Huntington\u2019s disease phenotypes.","volume":"144","author":"Birolini","year":"","journal-title":"Brain"},{"key":"B21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.neulet.2013.09.003","article-title":"Oxysterols and Parkinson\u2019s disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease.","volume":"555","author":"Bj\u00f6rkhem","year":"2013","journal-title":"Neurosci. Lett."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease.","volume":"205","author":"Bj\u00f6rkqvist","year":"2008","journal-title":"J. Exp. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1523\/JNEUROSCI.23-09-03807.2003","article-title":"Gene microarrays in hippocampal aging: statistical profiling identifies novel processes correlated with cognitive impairment.","volume":"23","author":"Blalock","year":"2003","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.neuron.2017.04.043","article-title":"Diverse requirements for microglial survival, specification, and function revealed by defined-medium cultures.","volume":"94","author":"Bohlen","year":"2017","journal-title":"Neuron"},{"key":"B25","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/brain\/awv384","article-title":"CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington\u2019s disease.","volume":"139","author":"Boussicault","year":"2016","journal-title":"Brain J. Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/jcbfm.2014.110","article-title":"Impaired brain energy metabolism in the BACHD mouse model of Huntington\u2019s disease: critical role of astrocyte\u2013neuron interactions.","volume":"34","author":"Boussicault","year":"2014","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.biochi.2018.07.019","article-title":"CYP46A1 protects against NMDA-mediated excitotoxicity in Huntington\u2019s disease: Analysis of lipid raft content.","volume":"153","author":"Boussicault","year":"2018","journal-title":"Biochimie"},{"key":"B28","doi-asserted-by":"publisher","first-page":"22480","DOI":"10.1073\/pnas.0911503106","article-title":"Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms.","volume":"106","author":"Bradford","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B29","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/s0022-2275(20)32393-2","article-title":"Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface.","volume":"41","author":"Bretillon","year":"2000","journal-title":"J. Lipid Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"20278","DOI":"10.1074\/jbc.270.35.20278","article-title":"Use of an 18O2 inhalation technique and mass isotopomer distribution analysis to study oxygenation of cholesterol in rat. Evidence for in vivo formation of 7- oxo-, 7 beta- hydroxy-, 24- hydroxy-, and 25-hydroxycholesterol.","volume":"270","author":"Breuer","year":"1995","journal-title":"J. Biol. Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1111\/j.1471-4159.2005.03515.x","article-title":"3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington\u2019s disease.","volume":"95","author":"Brouillet","year":"2005","journal-title":"J. Neurochem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/j.1742-4658.2008.06808.x","article-title":"SREBPs: SREBP function in glia-neuron interactions.","volume":"276","author":"Camargo","year":"2009","journal-title":"FEBS J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1111\/ejn.15218","article-title":"Cholesterol-recognition motifs in the transmembrane domain of the tyrosine kinase receptor family: The case of TRKB.","volume":"53","author":"Cannarozzo","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cell.2021.01.034","article-title":"Antidepressant drugs act by directly binding to TRKB neurotrophin receptors.","volume":"184","author":"Casarotto","year":"2021","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0606-1","article-title":"Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer\u2019s disease.","volume":"6","author":"Ceyz\u00e9riat","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"B36","doi-asserted-by":"publisher","first-page":"12218","DOI":"10.1073\/pnas.0502698102","article-title":"Unraveling a role for dopamine in Huntington\u2019s disease: the dual role of reactive oxygen species and D2 receptor stimulation.","volume":"102","author":"Charvin","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3233\/JHD-150181","article-title":"Partial Amelioration of Peripheral and Central Symptoms of Huntington\u2019s Disease via Modulation of Lipid Metabolism.","volume":"5","author":"Chen","year":"2016","journal-title":"J. Huntingt. Dis."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-014-0085-7","article-title":"Statin treatment affects cytokine release and phagocytic activity in primary cultured microglia through two separable mechanisms.","volume":"7","author":"Churchward","year":"2014","journal-title":"Mol. Brain"},{"key":"B39","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/brain\/awz363","article-title":"Microglial depletion prevents extracellular matrix changes and striatal volume reduction in a model of Huntington\u2019s disease.","volume":"143","author":"Crapser","year":"2020","journal-title":"Brain"},{"key":"B40","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nn.3668","article-title":"Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors.","volume":"17","author":"Crotti","year":"2014","journal-title":"Nat. Neurosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1007\/s12035-020-02232-6","article-title":"Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets.","volume":"58","author":"Dai","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/b978-1-4831-9939-9.50011-5","article-title":"Brain sterol metabolism.","volume":"3","author":"Davison","year":"1965","journal-title":"Adv. Lipid Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1471-4159.2010.06912.x","article-title":"Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington\u2019s disease.","volume":"115","author":"del Toro","year":"2010","journal-title":"J. Neurochem."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008287","article-title":"Dopamine D2 receptor stimulation potentiates PolyQ-Huntingtin-induced mouse striatal neuron dysfunctions via Rho\/ROCK-II activation.","volume":"4","author":"Deyts","year":"2009","journal-title":"PloS One"},{"key":"B45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1471-4159.1973.tb04224.x","article-title":"Biosynthesis of cholest-5-ene-3beta, 24-diol (cerebrosterol) by bovine cerebral cortical microsomes.","volume":"21","author":"Dhar","year":"1973","journal-title":"J. Neurochem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/hmg\/ddz298","article-title":"Mutant huntingtin interacts with the sterol regulatory element-binding proteins and impairs their nuclear import.","volume":"29","author":"Di Pardo","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"B47","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1515\/BC.2009.035","article-title":"Central nervous system: cholesterol turnover, brain development and neurodegeneration.","volume":"390","author":"Dietschy","year":"2009","journal-title":"Biol. Chem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","article-title":"Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal.","volume":"45","author":"Dietschy","year":"2004","journal-title":"J. Lipid Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"B50","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1113\/JP273106","article-title":"Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration.","volume":"595","author":"Dinan","year":"2017","journal-title":"J. Physiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/81593","article-title":"Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice.","volume":"26","author":"Dragatsis","year":"2000","journal-title":"Nat. Genet."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/mds.25992","article-title":"Metabolism in HD: still a relevant mechanism?","volume":"29","author":"Duan","year":"2014","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.neurobiolaging.2007.04.002","article-title":"A blueberry-enriched diet provides cellular protection against oxidative stress and reduces a kainate-induced learning impairment in rats.","volume":"29","author":"Duffy","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"B54","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/hbm.21205","article-title":"Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington\u2019s disease.","volume":"33","author":"Dumas","year":"2012","journal-title":"Hum. Brain Mapp."},{"key":"B55","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.7618107","article-title":"Inactivation of the mouse Huntington\u2019s disease gene homolog Hdh.","volume":"269","author":"Duyao","year":"1995","journal-title":"Science"},{"key":"B56","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1006\/abio.1995.1110","article-title":"Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry.","volume":"225","author":"Dzeletovic","year":"1995","journal-title":"Anal. Biochem."},{"key":"B57","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12035-014-8663-3","article-title":"Mitochondrial membrane fluidity is consistently increased in different models of Huntington disease: restorative effects of olesoxime.","volume":"50","author":"Eckmann","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/cns.13070","article-title":"Complete but not partial inhibition of glutamate transporters exacerbates cortical excitability in the R6\/2 mouse model of Huntington\u2019s disease.","volume":"25","author":"Estrada-S\u00e1nchez","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"B59","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.nbd.2008.12.017","article-title":"Glutamate toxicity in the striatum of the R6\/2 Huntington\u2019s disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters.","volume":"34","author":"Estrada-S\u00e1nchez","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1093\/hmg\/ddq212","article-title":"In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington\u2019s disease subjects.","volume":"19","author":"Faideau","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"B61","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1212\/WNL.0b013e3181d6476a","article-title":"Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe.","volume":"74","author":"Feldman","year":"2010","journal-title":"Neurology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1007\/s12035-013-8591-7","article-title":"Mutations of the Huntington\u2019s disease protein impact on the ATM-dependent signaling and repair pathways of the radiation-induced DNA double-strand breaks: corrective effect of statins and bisphosphonates.","volume":"49","author":"Ferlazzo","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/hipo.20548","article-title":"Cholesterol-promoted synaptogenesis requires the conversion of cholesterol to estradiol in the hippocampus.","volume":"19","author":"Fester","year":"2009","journal-title":"Hippocampus"},{"key":"B64","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1038\/emboj.2010.237","article-title":"Lysosomal fusion and SNARE function are impaired by cholesterol accumulation in lysosomal storage disorders.","volume":"29","author":"Fraldi","year":"2010","journal-title":"EMBO J."},{"key":"B65","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1136\/jmg.2009.066399","article-title":"Wild-type but not mutant huntingtin modulates the transcriptional activity of liver X receptors.","volume":"46","author":"Futter","year":"2009","journal-title":"J. Med. Genet."},{"key":"B66","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.neurobiolaging.2005.01.017","article-title":"Blueberry supplemented diet reverses age-related decline in hippocampal HSP70 neuroprotection.","volume":"27","author":"Galli","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"B67","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1021\/acs.biochem.5b00900","article-title":"Cholesterol Modifies Huntingtin Binding to, Disruption of, and Aggregation on Lipid Membranes.","volume":"55","author":"Gao","year":"2016","journal-title":"Biochemistry"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1006\/bbrc.2001.2008","article-title":"Membrane-bound enzymes of cholesterol synthesis from lanosterol.","volume":"292","author":"Gaylor","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B69","doi-asserted-by":"publisher","first-page":"10959","DOI":"10.1021\/bi963138w","article-title":"Cholesterol as modulator of receptor function.","volume":"36","author":"Gimpl","year":"1997","journal-title":"Biochemistry"},{"key":"B70","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway.","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"B71","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.brainresbull.2007.08.005","article-title":"Time-lapse analysis of aggregate formation in an inducible PC12 cell model of Huntington\u2019s disease reveals time-dependent aggregate formation that transiently delays cell death.","volume":"75","author":"Gong","year":"2008","journal-title":"Brain Res. Bull."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/mds.28089","article-title":"Dysregulated Brain Cholesterol Metabolism Is Linked to Neuroinflammation in Huntington\u2019s Disease.","volume":"35","author":"Gonz\u00e1lez-Guevara","year":"2020","journal-title":"Mov. Disord."},{"key":"B73","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.mcn.2005.02.006","article-title":"Multiple mechanisms mediate cholesterol-induced synaptogenesis in a CNS neuron.","volume":"29","author":"Goritz","year":"2005","journal-title":"Mol. Cell. Neurosci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1001\/archneur.1992.00530350075022","article-title":"Serial Changes of Cerebral Glucose Metabolism and Caudate Size in Persons at Risk for Huntington\u2019s Disease.","volume":"49","author":"Grafton","year":"1992","journal-title":"Arch. Neurol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/mdc3.12866","article-title":"Characterizing White Matter in Huntington\u2019s Disease.","volume":"7","author":"Gregory","year":"2020","journal-title":"Mov. Disord. Clin. Pract."},{"key":"B76","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/BF00194305","article-title":"The epidemiology of Huntington\u2019s disease.","volume":"89","author":"Harper","year":"1992","journal-title":"Hum. Genet."},{"key":"B77","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1523\/JNEUROSCI.23-08-03262.2003","article-title":"Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability.","volume":"23","author":"Hering","year":"2003","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"8790","DOI":"10.1523\/JNEUROSCI.0168-16.2016","article-title":"Mutant Huntingtin Impairs BDNF Release from Astrocytes by Disrupting Conversion of Rab3a-GTP into Rab3a-GDP.","volume":"36","author":"Hong","year":"2016","journal-title":"J. Neurosci."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1042\/bst0301091","article-title":"Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis.","volume":"30","author":"Horton","year":"2002","journal-title":"Biochem. Soc. Trans."},{"key":"B80","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.mcn.2008.02.010","article-title":"Regulation of AMPA receptor localization in lipid rafts.","volume":"38","author":"Hou","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.neuron.2015.02.026","article-title":"Mutant Huntingtin Downregulates Myelin Regulatory Factor-Mediated Myelin Gene Expression and Affects Mature Oligodendrocytes.","volume":"85","author":"Huang","year":"2015","journal-title":"Neuron"},{"key":"B82","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/mds.26152","article-title":"Statins, plasma cholesterol, and risk of Parkinson\u2019s disease: a prospective study.","volume":"30","author":"Huang","year":"2015","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"B83","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neuroscience.2016.04.043","article-title":"Cholesterol overload induces apoptosis in SH-SY5Y human neuroblastoma cells through the up regulation of flotillin-2 in the lipid raft and the activation of BDNF\/Trkb signaling.","volume":"328","author":"Huang","year":"2016","journal-title":"Neuroscience"},{"key":"B84","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","article-title":"Identification of Genetic Factors that Modify Clinical Onset of Huntington\u2019s Disease.","volume":"162","year":"2015","journal-title":"Cell"},{"key":"B85","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.cell.2019.06.036","article-title":"CAG Repeat Not Polyglutamine Length Determines Timing of Huntington\u2019s Disease Onset.","volume":"178","year":"2019","journal-title":"Cell"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.neurobiolaging.2009.07.006","article-title":"Oxidative stress activates the pro-survival TrkA pathway through membrane cholesterol loss.","volume":"32","author":"Iannilli","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fnsyn.2021.618391","article-title":"Disposition of Proteins and Lipids in Synaptic Membrane Compartments Is Altered in Q175\/Q7 Huntington\u2019s Disease Mouse Striatum.","volume":"13","author":"Iuliano","year":"2021","journal-title":"Front. Synaptic Neurosci."},{"key":"B88","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/glia.23050","article-title":"Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell\u2212type\u2212specific.","volume":"65","author":"Jansen","year":"2017","journal-title":"Glia"},{"key":"B89","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/s0022-2275(20)39816-3","article-title":"Regulation of rates of cholesterol synthesis in vivo in the liver and carcass of the rat measured using [3H]water.","volume":"21","author":"Jeske","year":"1980","journal-title":"J. Lipid Res."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2020.108698","article-title":"Mitochondrial dysfunction in the development and progression of neurodegenerative diseases.","volume":"702","author":"Johnson","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1093\/brain\/awz174","article-title":"CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington\u2019s disease.","volume":"142","author":"Kacher","year":"2019","journal-title":"Brain J. Neurol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrneurol.2011.132","article-title":"Cholesterol metabolism in Huntington disease.","volume":"7","author":"Karasinska","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.neulet.2004.07.031","article-title":"Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients.","volume":"368","author":"K\u00f6lsch","year":"2004","journal-title":"Neurosci. Lett."},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2018.09.001","article-title":"Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington\u2019s disease.","volume":"135","author":"Kong","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69454-5","article-title":"Cholesterol modulates presynaptic and postsynaptic properties of excitatory synaptic transmission.","volume":"10","author":"Korinek","year":"2020","journal-title":"Sci. Rep."},{"key":"B96","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1007\/s00216-011-5002-7","article-title":"Cholesterol effects on vesicle pools in chromaffin cells revealed by carbon-fiber microelectrode amperometry.","volume":"400","author":"Koseoglu","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"key":"B97","doi-asserted-by":"publisher","first-page":"11394","DOI":"10.1073\/pnas.0805556105","article-title":"Biphasic requirement for geranylgeraniol in hippocampal long-term potentiation.","volume":"105","author":"Kotti","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B98","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1073\/pnas.0600316103","article-title":"Brain cholesterol turnover required for geranylgeraniol production and learning in mice.","volume":"103","author":"Kotti","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B99","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jns.2004.11.036","article-title":"Cholesterol homeostasis failure as a unifying cause of synaptic degeneration.","volume":"22","author":"Koudinov","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"B100","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3233\/JHD-150170","article-title":"Brain Cholesterol Synthesis and Metabolism is Progressively Disturbed in the R6\/1 Mouse Model of Huntington\u2019s Disease: A Targeted GC-MS\/MS Sterol Analysis.","volume":"4","author":"Kreilaus","year":"2015","journal-title":"J. Huntingt. Dis."},{"key":"B101","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3233\/JHD-160204","article-title":"Therapeutic Effects of Anthocyanins and Environmental Enrichment in R6\/1 Huntington\u2019s Disease Mice.","volume":"5","author":"Kreilaus","year":"","journal-title":"J. Huntingt. Dis."},{"key":"B102","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/nan.12286","article-title":"Evidence for altered cholesterol metabolism in Huntington\u2019s disease post mortem brain tissue.","volume":"42","author":"Kreilaus","year":"","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2013.03.042","article-title":"Synergistical neuroprotection of rofecoxib and statins against malonic acid induced Huntington\u2019s disease like symptoms and related cognitive dysfunction in rats.","volume":"709","author":"Kumar","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","article-title":"A new model for prediction of the age of onset and penetrance for Huntington\u2019s disease based on CAG length.","volume":"65","author":"Langbehn","year":"2004","journal-title":"Clin. Genet."},{"key":"B105","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.bcp.2013.03.015","article-title":"Potential diagnostic applications of side chain oxysterols analysis in plasma and cerebrospinal fluid.","volume":"86","author":"Leoni","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.bbalip.2014.12.018","article-title":"The impairment of cholesterol metabolism in Huntington disease.","volume":"1851","author":"Leoni","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"B107","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.nbd.2013.03.013","article-title":"Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression.","volume":"55","author":"Leoni","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"B108","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neulet.2011.03.025","article-title":"Whole body cholesterol metabolism is impaired in Huntington\u2019s disease.","volume":"494","author":"Leoni","year":"2011","journal-title":"Neurosci. Lett."},{"key":"B109","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1093\/brain\/awn212","article-title":"Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington\u2019s disease.","volume":"131","author":"Leoni","year":"2008","journal-title":"Brain J. Neurol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/78054","article-title":"Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity.","volume":"25","author":"Li","year":"2000","journal-title":"Nat. Genet."},{"key":"B111","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.neuron.2021.01.005","article-title":"Astrocytic ApoE reprograms neuronal cholesterol metabolism and histone-acetylation-mediated memory.","volume":"109","author":"Li","year":"2021","journal-title":"Neuron"},{"key":"B112","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.nbd.2010.11.018","article-title":"Proteasomal dysfunction in aging and Huntington disease.","volume":"43","author":"Li","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"B113","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia.","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1002\/mds.28474","article-title":"A Double-Blind, Randomized, Controlled Trial of Lovastatin in Early-Stage Parkinson\u2019s Disease.","volume":"36","author":"Lin","year":"2021","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002143","article-title":"Early Statin Use and the Progression of Alzheimer Disease: A Total Population-Based Case-Control Study.","volume":"94","author":"Lin","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"B116","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/mds.27006","article-title":"Statins may facilitate Parkinson\u2019s disease: Insight gained from a large, national claims database.","volume":"32","author":"Liu","year":"2017","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1038\/s41593-019-0511-3","article-title":"Neuronal network activity controls microglial process surveillance in awake mice via norepinephrine signaling.","volume":"22","author":"Liu","year":"2019","journal-title":"Nat. Neurosci."},{"key":"B118","doi-asserted-by":"publisher","first-page":"7238","DOI":"10.1073\/pnas.96.13.7238","article-title":"cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain.","volume":"96","author":"Lund","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B119","doi-asserted-by":"publisher","first-page":"22980","DOI":"10.1074\/jbc.M303415200","article-title":"Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover.","volume":"278","author":"Lund","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B120","doi-asserted-by":"publisher","first-page":"7927","DOI":"10.1073\/pnas.1002924107","article-title":"SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis.","volume":"107","author":"Luthi-Carter","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B121","doi-asserted-by":"publisher","first-page":"9799","DOI":"10.1073\/pnas.93.18.9799","article-title":"Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation.","volume":"93","author":"L\u00fctjohann","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B122","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/s0022-2275(20)32052-6","article-title":"Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients.","volume":"41","author":"L\u00fctjohann","year":"2000","journal-title":"J. Lipid Res."},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068534","article-title":"Is it possible to improve memory function by upregulation of the cholesterol 24S-hydroxylase (CYP46A1) in the brain?","volume":"8","author":"Maioli","year":"2013","journal-title":"PloS One"},{"key":"B124","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.tins.2014.09.003","article-title":"Autophagy in Huntington disease and huntingtin in autophagy.","volume":"38","author":"Martin","year":"2015","journal-title":"Trends Neurosci."},{"key":"B125","doi-asserted-by":"publisher","first-page":"902","DOI":"10.15252\/emmm.201303711","article-title":"Constitutive hippocampal cholesterol loss underlies poor cognition in old rodents.","volume":"6","author":"Martin","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"B126","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1091\/mbc.e07-09-0897","article-title":"Cholesterol loss enhances TrkB signaling in hippocampal neurons aging in vitro.","volume":"19","author":"Martin","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"B127","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.neurobiolaging.2009.04.022","article-title":"Cyp46-mediated cholesterol loss promotes survival in stressed hippocampal neurons.","volume":"32","author":"Martin","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1371\/505886e9a1968","article-title":"Pitfalls in the detection of cholesterol in Huntington\u2019s disease models.","volume":"4","author":"Marullo","year":"2012","journal-title":"PLoS Curr."},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187168","article-title":"Transcriptional and post-translational changes in the brain of mice deficient in cholesterol removal mediated by cytochrome P450 46A1 (CYP46A1).","volume":"12","author":"Mast","year":"2017","journal-title":"PloS One"},{"key":"B130","doi-asserted-by":"publisher","first-page":"14284","DOI":"10.1021\/bi035512f","article-title":"Broad substrate specificity of human cytochrome P450 46A1 which initiates cholesterol degradation in the brain.","volume":"42","author":"Mast","year":"2003","journal-title":"Biochemistry"},{"key":"B131","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/s1388-1981(00)00070-6","article-title":"Formation of oxysterols from different pools of cholesterol as studied by stable isotope technique: cerebral origin of most circulating 24S-hydroxycholesterol in rats, but not in mice.","volume":"1486","author":"Meaney","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"B132","doi-asserted-by":"publisher","first-page":"7587","DOI":"10.1073\/pnas.1424951112","article-title":"Liver X receptors alpha and beta promote myelination and remyelination in the cerebellum.","volume":"112","author":"Meffre","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B133","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.neuroscience.2008.02.004","article-title":"Up-regulation of GLT1 Expression Increases Glutamate Uptake and Attenuates the Huntington\u2019s Disease Phenotype in the R6\/2 Mouse.","volume":"153","author":"Miller","year":"2008","journal-title":"Neuroscience"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000647","article-title":"Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression.","volume":"2","author":"Mochel","year":"2007","journal-title":"PloS One"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1161\/CIRCULATIONAHA.108.782300","article-title":"Activation of liver X receptors promotes neuroprotection and reduces brain inflammation in experimental stroke.","volume":"118","author":"Morales","year":"2008","journal-title":"Circulation"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2013.00127","article-title":"Multiple Aspects of Gene Dysregulation in Huntington\u2019s Disease.","volume":"4","author":"Moumn\u00e9","year":"2013","journal-title":"Front. Neurol."},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1038\/srep30928","article-title":"Neuronal cholesterol metabolism increases dendritic outgrowth and synaptic markers via a concerted action of GGTase-I and Trk.","volume":"6","author":"Moutinho","year":"2016","journal-title":"Sci. Rep."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s12035-014-8828-0","article-title":"Cholesterol 24S-Hydroxylase Overexpression Inhibits the Liver X Receptor (LXR) Pathway by Activating Small Guanosine Triphosphate-Binding Proteins (sGTPases) in Neuronal Cells.","volume":"51","author":"Moutinho","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.yexcr.2017.02.034","article-title":"The mevalonate pathway in neurons: It\u2019s not just about cholesterol.","volume":"360","author":"Moutinho","year":"2017","journal-title":"Exp. Cell Res."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.aca.2013.06.012","article-title":"Raman spectroscopy and partial least squares analysis in discrimination of peripheral cells affected by Huntington\u2019s disease.","volume":"793","author":"Muratore","year":"2013","journal-title":"Anal. Chim. Acta"},{"key":"B141","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1021\/acsnano.0c09159","article-title":"Liver X Receptor Activation with an Intranasal Polymer Therapeutic Prevents Cognitive Decline without Altering Lipid Levels.","volume":"15","author":"Navas Guimaraes","year":"2021","journal-title":"ACS Nano"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-020-05053-x","article-title":"The cholesterol 24-hydroxylase activates autophagy and decreases mutant huntingtin build-up in a neuroblastoma culture model of Huntington\u2019s disease.","volume":"13","author":"N\u00f3brega","year":"2020","journal-title":"BMC Res. Notes"},{"key":"B143","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s00401-019-02019-7","article-title":"Restoring brain cholesterol turnover improves autophagy and has therapeutic potential in mouse models of spinocerebellar ataxia.","volume":"138","author":"N\u00f3brega","year":"2019","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-016-1553-1","article-title":"The role of glial specific Kir4.1 in normal and pathological states of the CNS.","volume":"132","author":"Nwaobi","year":"2016","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"B145","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1074\/jbc.M505179200","article-title":"Studies on the transcriptional regulation of cholesterol 24-hydroxylase (CYP46A1): marked insensitivity toward different regulatory axes.","volume":"281","author":"Ohyama","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02147-6","article-title":"Human Huntington\u2019s disease pluripotent stem cell-derived microglia develop normally but are abnormally hyper-reactive and release elevated levels of reactive oxygen species.","volume":"18","author":"O\u2019Regan","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1093\/brain\/awt083","article-title":"Reactive glia show increased immunoproteasome activity in Alzheimer\u2019s disease.","volume":"136","author":"Orre","year":"2013","journal-title":"Brain J. Neurol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1523\/JNEUROSCI.5673-09.2010","article-title":"Acute polyglutamine expression in inducible mouse model unravels ubiquitin\/proteasome system impairment and permanent recovery attributable to aggregate formation.","volume":"30","author":"Ortega","year":"2010","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"B149","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10038-007-0227-1","article-title":"Huntington disease mutation in Venezuela: age of onset, haplotype analyses and geographic aggregation.","volume":"53","author":"Paradisi","year":"2008","journal-title":"J. Hum. Genet."},{"key":"B150","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1021\/acschemneuro.9b00581","article-title":"Efficacy of Cholesterol Nose-to-Brain Delivery for Brain Targeting in Huntington\u2019s Disease.","volume":"11","author":"Passoni","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"B151","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.neulet.2008.10.023","article-title":"Effects of simvastatin on neuroprotection and modulation of Bcl-2 and BAX in the rat quinolinic acid model of Huntington\u2019s disease.","volume":"448","author":"Patassini","year":"2008","journal-title":"Neurosci. Lett."},{"key":"B152","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/B978-0-444-63233-3.00009-9","article-title":"Repeat expansion diseases.","volume":"147","author":"Paulson","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","article-title":"Microglial activation correlates with severity in Huntington disease: A clinical and PET study.","volume":"66","author":"Pavese","year":"2006","journal-title":"Neurology"},{"key":"B154","doi-asserted-by":"publisher","first-page":"10625","DOI":"10.1073\/pnas.91.22.10625","article-title":"Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization.","volume":"91","author":"Pellerin","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B155","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/jcbfm.2011.149","article-title":"Sweet sixteen for ANLS.","volume":"32","author":"Pellerin","year":"2012","journal-title":"J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1093\/hmg\/ddz009","article-title":"Mutant huntingtin expression in microglia is neither required nor sufficient to cause the Huntington\u2019s disease-like phenotype in BACHD mice.","volume":"28","author":"Petkau","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"B157","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1111\/ejn.12202","article-title":"Decreased expression of GLT-1 in the R6\/2 model of Huntington\u2019s disease does not worsen disease progression.","volume":"38","author":"Petr","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"B158","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s13311-019-00737-0","article-title":"CYP46A1 Activation by Efavirenz Leads to Behavioral Improvement without Significant Changes in Amyloid Plaque Load in the Brain of 5XFAD Mice.","volume":"16","author":"Petrov","year":"","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."},{"key":"B159","doi-asserted-by":"publisher","first-page":"8782","DOI":"10.1096\/fj.201900092R","article-title":"The key genes, phosphoproteins, processes, and pathways affected by efavirenz-activated CYP46A1 in the amyloid-decreasing paradigm of efavirenz treatment.","volume":"33","author":"Petrov","year":"","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3233\/JHD-180321","article-title":"Striatal Cholesterol Precursors Are Altered with Age in Female Huntington\u2019s Disease Model Mice.","volume":"8","author":"Pfalzer","year":"2019","journal-title":"J. Huntingt. Dis."},{"key":"B161","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.plipres.2011.06.002","article-title":"Cholesterol metabolism in neurons and astrocytes.","volume":"50","author":"Pfrieger","year":"2011","journal-title":"Prog. Lipid Res."},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76973-8","article-title":"Cholesteryl ester levels are elevated in the caudate and putamen of Huntington\u2019s disease patients.","volume":"10","author":"Phillips","year":"2020","journal-title":"Sci. Rep."},{"key":"B163","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1089\/hum.2020.105","article-title":"The Challenge of Gene Therapy for Neurological Diseases: Strategies and Tools to Achieve Efficient Delivery to the Central Nervous System.","volume":"32","author":"Piguet","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.696778","article-title":"Cholesterol Hydroxylating Cytochrome P450 46A1: From Mechanisms of Action to Clinical Applications.","volume":"13","author":"Pikuleva","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"B165","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.nbd.2015.08.011","article-title":"Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington\u2019s disease gene carriers.","volume":"83","author":"Politis","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"B166","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/hbm.21008","article-title":"Microglial activation in regions related to cognitive function predicts disease onset in Huntington\u2019s disease: A multimodal imaging study.","volume":"32","author":"Politis","year":"2010","journal-title":"Hum. Brain Mapp."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.cmet.2019.03.004","article-title":"Metabolic Reprogramming in Astrocytes Distinguishes Region-Specific Neuronal Susceptibility in Huntington Mice.","volume":"29","author":"Polyzos","year":"2019","journal-title":"Cell Metab"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1001\/archneur.62.7.1047","article-title":"Statin use and the risk of incident dementia: the Cardiovascular Health Study.","volume":"62","author":"Rea","year":"2005","journal-title":"Arch. Neurol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/s0969-9961(02)00008-6","article-title":"Complement-receptor-3 and scavenger-receptor-AI\/II mediated myelin phagocytosis in microglia and macrophages.","volume":"12","author":"Reichert","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"B170","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mcn.2012.03.011","article-title":"Multiple phenotypes in Huntington disease mouse neural stem cells.","volume":"50","author":"Ritch","year":"2012","journal-title":"Mol. Cell. Neurosci."},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000984","article-title":"Microglia Activation in Basal Ganglia Is a Late Event in Huntington Disease Pathophysiology.","volume":"8","author":"Rocha","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflam."},{"key":"B172","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/b978-0-12-024914-5.50008-5","article-title":"Regulation of HMG-CoA reductase.","volume":"14","author":"Rodwell","year":"1976","journal-title":"Adv. Lipid Res."},{"key":"B173","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.devcel.2021.03.032","article-title":"Lipid-mediated motor-adaptor sequestration impairs axonal lysosome delivery leading to autophagic stress and dystrophy in Niemann-Pick type C.","volume":"56","author":"Roney","year":"2021","journal-title":"Dev. Cell"},{"key":"B174","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1093\/brain\/awn025","article-title":"Cerebral cortex and the clinical expression of Huntington\u2019s disease: complexity and heterogeneity.","volume":"131","author":"Rosas","year":"2008","journal-title":"Brain J. Neurol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington\u2019s disease: from molecular pathogenesis to clinical treatment.","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175054","article-title":"Statin adherence and the risk of Parkinson\u2019s disease: A population-based cohort study.","volume":"12","author":"Rozani","year":"2017","journal-title":"PloS One"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2011.00055","article-title":"Huntington\u2019s Disease and Striatal Signaling.","volume":"5","author":"Roze","year":"2011","journal-title":"Front. Neuroanat."},{"key":"B178","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1073\/pnas.76.1.15","article-title":"Lateral diffusion in binary mixtures of cholesterol and phosphatidylcholines.","volume":"76","author":"Rubenstein","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01965-4","article-title":"Astrocytes from cortex and striatum show differential responses to mitochondrial toxin and BDNF: implications for protection of striatal neurons expressing mutant huntingtin.","volume":"17","author":"Saba","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"B180","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.bbalip.2015.02.010","article-title":"Cholesterol in myelin biogenesis and hypomyelinating disorders.","volume":"1851","author":"Saher","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"B181","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s40618-014-0098-1","article-title":"Altered expression of 3-betahydroxysterol delta-24-reductase\/selective Alzheimer\u2019s disease indicator-1 gene in Huntington\u2019s disease models.","volume":"37","author":"Samara","year":"2014","journal-title":"J. Endocrinol. Invest."},{"key":"B182","doi-asserted-by":"publisher","first-page":"10670","DOI":"10.1021\/bi00499a014","article-title":"Interaction of cholesterol with various glycerophospholipids and sphingomyelin.","volume":"29","author":"Sankaram","year":"","journal-title":"Biochemistry"},{"key":"B183","doi-asserted-by":"publisher","first-page":"10676","DOI":"10.1021\/bi00499a015","article-title":"Modulation of phospholipid acyl chain order by cholesterol. A solid-state 2H nuclear magnetic resonance study.","volume":"29","author":"Sankaram","year":"","journal-title":"Biochemistry"},{"key":"B184","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and Progressive Accumulation of Reactive Microglia in the Huntington Disease Brain.","volume":"60","author":"Sapp","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/s0092-8674(00)81782-1","article-title":"Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.","volume":"95","author":"Saudou","year":"1998","journal-title":"Cell"},{"key":"B186","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The Biology of Huntingtin.","volume":"89","author":"Saudou","year":"2016","journal-title":"Neuron"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01782-9","article-title":"Microglial physiological properties and interactions with synapses are altered at presymptomatic stages in a mouse model of Huntington\u2019s disease pathology.","volume":"17","author":"Savage","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"B188","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1016\/j.bbamem.2012.07.032","article-title":"Membrane cholesterol stabilizes the human serotonin(1A) receptor.","volume":"1818","author":"Saxena","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"B189","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/s0092-8674(00)80514-0","article-title":"Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo.","volume":"90","author":"Scherzinger","year":"1997","journal-title":"Cell"},{"key":"B190","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/s0304-3940(02)00164-7","article-title":"Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer\u2019s disease compared to healthy controls.","volume":"324","author":"Sch\u00f6nknecht","year":"2002","journal-title":"Neurosci. Lett."},{"key":"B191","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/mds.27591","article-title":"Statin use and delayed onset of Huntington\u2019s disease.","volume":"34","author":"Schultz","year":"2019","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"B192","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1046\/j.1471-4159.2003.02305.x","article-title":"HMG-CoA reductase inhibition causes neurite loss by interfering with geranylgeranylpyrophosphate synthesis.","volume":"89","author":"Schulz","year":"2004","journal-title":"J. Neurochem."},{"key":"B193","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2796.2011.02389.x","article-title":"Enhanced production of 24S-hydroxycholesterol is not sufficient to drive liver X receptor target genes in vivo.","volume":"270","author":"Shafaati","year":"2011","journal-title":"J. Intern. Med."},{"key":"B194","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.nbd.2016.11.013","article-title":"Early and brain region-specific decrease of de novo cholesterol biosynthesis in Huntington\u2019s disease: A cross-validation study in Q175 knock-in mice.","volume":"98","author":"Shankaran","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"B195","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbr.2016.04.046","article-title":"Statin use and risk of Parkinson\u2019s disease: A meta-analysis.","volume":"309","author":"Sheng","year":"2016","journal-title":"Behav. Brain Res."},{"key":"B196","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1083\/jcb.200508072","article-title":"Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity.","volume":"171","author":"Shin","year":"2005","journal-title":"J. Cell Biol."},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11441-0","article-title":"Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington\u2019s disease.","volume":"10","author":"Siew","year":"2019","journal-title":"Nat. Commun."},{"key":"B198","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1097\/WNR.0b013e32832e34ee","article-title":"Distinct neuroinflammatory profile in post-mortem human Huntington\u2019s disease.","volume":"20","author":"Silvestroni","year":"2009","journal-title":"Neuroreport"},{"key":"B199","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1006\/exnr.1999.7170","article-title":"Increased complement biosynthesis by microglia and complement activation on neurons in Huntington\u2019s disease.","volume":"159","author":"Singhrao","year":"1999","journal-title":"Exp. Neurol."},{"key":"B200","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/hmg\/11.17.1953","article-title":"Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses.","volume":"11","author":"Sipione","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"B201","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s11745-013-3836-9","article-title":"Aging induces tissue-specific changes in cholesterol metabolism in rat brain and liver.","volume":"48","author":"Smiljanic","year":"2013","journal-title":"Lipids"},{"key":"B202","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1471-4159.1990.tb01889.x","article-title":"Lipid compositions of different regions of the human brain during aging.","volume":"54","author":"S\u00f6derberg","year":"1990","journal-title":"J. Neurochem."},{"key":"B203","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1038\/emboj.2012.31","article-title":"Cholesterol loss during glutamate-mediated excitotoxicity.","volume":"31","author":"Sodero","year":"2012","journal-title":"EMBO J."},{"key":"B204","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.neurobiolaging.2010.06.001","article-title":"Cellular stress from excitatory neurotransmission contributes to cholesterol loss in hippocampal neurons aging in vitro.","volume":"32","author":"Sodero","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"B205","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2174\/1567205054367900","article-title":"Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD.","volume":"2","author":"Sparks","year":"2005","journal-title":"Curr. Alzheimer Res."},{"key":"B206","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1021\/acs.jmedchem.6b00176","article-title":"Identification and in Vivo Evaluation of Liver X Receptor \u03b2-Selective Agonists for the Potential Treatment of Alzheimer\u2019s Disease.","volume":"59","author":"Stachel","year":"2016","journal-title":"J. Med. Chem."},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75229-9","article-title":"Increased intestinal permeability and gut dysbiosis in the R6\/2 mouse model of Huntington\u2019s disease.","volume":"10","author":"Stan","year":"2020","journal-title":"Sci. Rep."},{"key":"B208","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.bpj.2016.02.019","article-title":"Cholesterol Increases the Openness of SNARE-Mediated Flickering Fusion Pores.","volume":"110","author":"Stratton","year":"2016","journal-title":"Biophys. J."},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-5-44","article-title":"Systemic treatment with liver X receptor agonists raises apolipoprotein E, cholesterol, and amyloid-\u03b2 peptides in the cerebral spinal fluid of rats.","volume":"5","author":"Suon","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"B210","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1471-4159.2011.07404.x","article-title":"Association of membrane rafts and postsynaptic density: proteomics, biochemical, and ultrastructural analyses.","volume":"119","author":"Suzuki","year":"2011","journal-title":"J. Neurochem."},{"key":"B211","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1111\/j.1471-4159.1991.tb03466.x","article-title":"Membrane lipids in the aging human brain.","volume":"56","author":"Svennerholm","year":"1991","journal-title":"J. Neurochem."},{"key":"B212","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s004010050717","article-title":"Changes in weight and compositions of major membrane components of human brain during the span of adult human life of Swedes.","volume":"94","author":"Svennerholm","year":"1997","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"B213","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington\u2019s disease gene carriers.","volume":"130","author":"Tai","year":"2007","journal-title":"Brain J. Neurol."},{"key":"B214","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cell.2006.10.030","article-title":"Molecular anatomy of a trafficking organelle.","volume":"127","author":"Takamori","year":"2006","journal-title":"Cell"},{"key":"B215","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/s0304-3940(03)00667-0","article-title":"Decreased levels of the brain specific 24S-hydroxycholesterol and cholesterol precursors in serum of multiple sclerosis patients.","volume":"347","author":"Teunissen","year":"2003","journal-title":"Neurosci. Lett."},{"key":"B216","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-e","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"B217","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.neulet.2006.04.034","article-title":"Cholesterol synthesis rate in human hippocampus declines with aging.","volume":"403","author":"Thelen","year":"2006","journal-title":"Neurosci. Lett."},{"key":"B218","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nn.3691","article-title":"Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington\u2019s disease model mice.","volume":"17","author":"Tong","year":"2014","journal-title":"Nat. Neurosci."},{"key":"B219","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3233\/JHD-170245","article-title":"Fifteen Years of Clinical Trials in Huntington\u2019s Disease: A Very Low Clinical Drug Development Success Rate.","volume":"6","author":"Travessa","year":"2017","journal-title":"J. Huntingt. Dis."},{"key":"B220","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/hmg\/ddt406","article-title":"Loss of caveolin-1 expression in knock-in mouse model of Huntington\u2019s disease suppresses pathophysiology in vivo.","volume":"23","author":"Trushina","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B221","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1093\/hmg\/ddl434","article-title":"Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo.","volume":"15","author":"Trushina","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"B222","doi-asserted-by":"publisher","first-page":"4484","DOI":"10.1091\/mbc.E12-08-0631","article-title":"Differential regulation of HMG-CoA reductase and Insig-1 by enzymes of the ubiquitin-proteasome system.","volume":"23","author":"Tsai","year":"2012","journal-title":"Mol. Biol. Cell"},{"key":"B223","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s12035-016-0377-2","article-title":"Lanosterol Suppresses the Aggregation and Cytotoxicity of Misfolded Proteins Linked with Neurodegenerative Diseases.","volume":"55","author":"Upadhyay","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"B224","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1093\/hmg\/ddm170","article-title":"Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation.","volume":"16","author":"Valenza","year":"","journal-title":"Hum. Mol. Genet."},{"key":"B225","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.nbd.2007.07.004","article-title":"Progressive dysfunction of the cholesterol biosynthesis pathway in the R6\/2 mouse model of Huntington\u2019s disease.","volume":"28","author":"Valenza","year":"","journal-title":"Neurobiol. Dis."},{"key":"B226","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.tins.2011.06.005","article-title":"Emerging roles for cholesterol in Huntington\u2019s disease.","volume":"34","author":"Valenza","year":"2011","journal-title":"Trends Neurosci."},{"key":"B227","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.15252\/emmm.201505413","article-title":"Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington\u2019s disease mice.","volume":"7","author":"Valenza","year":"","journal-title":"EMBO Mol. Med."},{"key":"B228","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/cdd.2014.162","article-title":"Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington\u2019s disease.","volume":"22","author":"Valenza","year":"","journal-title":"Cell Death Differ."},{"key":"B229","doi-asserted-by":"publisher","first-page":"10844","DOI":"10.1523\/JNEUROSCI.0917-10.2010","article-title":"Cholesterol defect is marked across multiple rodent models of Huntington\u2019s disease and is manifest in astrocytes.","volume":"30","author":"Valenza","year":"2010","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"B230","doi-asserted-by":"publisher","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","article-title":"Dysfunction of the Cholesterol Biosynthetic Pathway in Huntington\u2019s Disease.","volume":"25","author":"Valenza","year":"2005","journal-title":"J. Neurosci."},{"key":"B231","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1242\/jcs.129270","article-title":"Late endosomal transport and tethering are coupled processes controlled by RILP and the cholesterol sensor ORP1L.","volume":"126","author":"van der Kant","year":"2013","journal-title":"J. Cell Sci."},{"key":"B232","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.neurobiolaging.2009.07.005","article-title":"Liver X receptor activation restores memory in aged AD mice without reducing amyloid.","volume":"32","author":"Vanmierlo","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb0799","article-title":"Increasing brain palmitoylation rescues behavior and neuropathology in Huntington disease mice.","volume":"7","author":"Virlogeux","year":"2021","journal-title":"Sci. Adv."},{"key":"B234","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.conb.2020.04.001","article-title":"Traffic signaling: new functions of huntingtin and axonal transport in neurological disease.","volume":"63","author":"Vitet","year":"2020","journal-title":"Curr. Opin. Neurobiol."},{"key":"B235","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington\u2019s disease.","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15270-4","article-title":"Different regions of synaptic vesicle membrane regulate VAMP2 conformation for the SNARE assembly.","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"B237","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/abbs\/gmr125","article-title":"Truncated N-terminal huntingtin fragment with expanded-polyglutamine (htt552-100Q) suppresses brain-derived neurotrophic factor transcription in astrocytes.","volume":"44","author":"Wang","year":"2012","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"B238","doi-asserted-by":"publisher","first-page":"13878","DOI":"10.1073\/pnas.172510899","article-title":"Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration.","volume":"99","author":"Wang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B239","doi-asserted-by":"publisher","first-page":"26332","DOI":"10.1074\/jbc.M804808200","article-title":"Regulation of cholesterologenesis by the oxysterol receptor.","volume":"283","author":"Wang","year":"2008","journal-title":"LXRalpha. J. Biol. Chem."},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa110","article-title":"Gut dysbiosis in Huntington\u2019s disease: associations among gut microbiota, cognitive performance and clinical outcomes.","volume":"2","author":"Wasser","year":"2020","journal-title":"Brain Commun."},{"key":"B241","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1113\/jphysiol.2006.123133","article-title":"Cholesterol-dependent balance between evoked and spontaneous synaptic vesicle recycling.","volume":"579","author":"Wasser","year":"2007","journal-title":"J. Physiol."},{"key":"B242","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1210\/mend.16.6.0835","article-title":"Regulation of cholesterol homeostasis by the liver X receptors in the central nervous system.","volume":"16","author":"Whitney","year":"2002","journal-title":"Mol. Endocrinol. Baltim. Md"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104963","article-title":"The contribution of glial cells to Huntington\u2019s disease pathogenesis.","volume":"143","author":"Wilton","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"B244","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","article-title":"Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.","volume":"57","author":"Wolozin","year":"2000","journal-title":"Arch. Neurol."},{"key":"B245","doi-asserted-by":"publisher","first-page":"9544","DOI":"10.1523\/JNEUROSCI.1291-11.2011","article-title":"Peroxisome-proliferator-activated receptor gamma coactivator 1 \u03b1 contributes to dysmyelination in experimental models of Huntington\u2019s disease.","volume":"31","author":"Xiang","year":"2011","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"B246","doi-asserted-by":"publisher","first-page":"608","DOI":"10.4103\/1673-5374.320999","article-title":"Profile of the RNA in exosomes from astrocytes and microglia using deep sequencing: implications for neurodegeneration mechanisms.","volume":"17","author":"Xie","year":"2022","journal-title":"Neural Regen. Res."},{"key":"B247","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/mp.2014.60","article-title":"Liver X receptor \u03b2 is essential for the differentiation of radial glial cells to oligodendrocytes in the dorsal cortex.","volume":"19","author":"Xu","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00193","article-title":"Microglial Activation in the Pathogenesis of Huntington\u2019s Disease.","volume":"9","author":"Yang","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"B249","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ng1095-155","article-title":"Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington\u2019s disease gene homologue.","volume":"11","author":"Zeitlin","year":"1995","journal-title":"Nat. Genet."},{"key":"B250","doi-asserted-by":"publisher","first-page":"10601","DOI":"10.1073\/pnas.0701096104","article-title":"Attenuation of neuroinflammation and Alzheimer\u2019s disease pathology by liver x receptors.","volume":"104","author":"Zelcer","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B251","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nature14650","article-title":"Lanosterol reverses protein aggregation in cataracts.","volume":"523","author":"Zhao","year":"2015","journal-title":"Nature"},{"key":"B252","doi-asserted-by":"publisher","first-page":"8317","DOI":"10.1523\/JNEUROSCI.0806-16.2016","article-title":"Compartment-Dependent Degradation of Mutant Huntingtin Accounts for Its Preferential Accumulation in Neuronal Processes.","volume":"36","author":"Zhao","year":"2016","journal-title":"J. Neurosci."},{"key":"B253","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","article-title":"Brain-derived neurotrophic factor in neurodegenerative diseases.","volume":"5","author":"Zuccato","year":"2009","journal-title":"Nat. Rev. Neurol."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.797220\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T14:04:15Z","timestamp":1650377055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.797220\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,19]]},"references-count":253,"alternative-id":["10.3389\/fnagi.2022.797220"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2022.797220","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,19]]},"article-number":"797220"}}